Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04536155
Other study ID # CHMS19002
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 2, 2020
Est. completion date October 2, 2023

Study information

Verified date June 2022
Source Centre Hospitalier Metropole Savoie
Contact Patricia TRIOLO
Phone 04.79.96.58.36
Email patricia.triolo@ch-metropole-savoie.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The benefit of learning psychocorporal techniques in Therapeutic Education on the quality of life of patients with chronic pain will be studied. The purpose of this nursing research protocol is to highlight the improvement of the quality of life of chronic pain patients through psycho-physical techniques performed during group therapeutic education workshops.


Description:

The study will be performed at Centre for the Study and Treatment of Pain. The patients with chronic pain will participate to a group programm of therapeutic education. The programm consists of 9 workshops about psycho-corporal techniques performed in group. The patients will complete questionnaries before beginning the program, at the end of the programm, 6 months after the end of the program, and 12 months after the end of program. The questionnaries will be SF36, HADS, CPAQ, and digital pain scale.


Recruitment information / eligibility

Status Recruiting
Enrollment 72
Est. completion date October 2, 2023
Est. primary completion date October 2, 2022
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - chronic pain since more the 3months - Patients for whom a group "relaxation techniques" program is planned and accepted by the patient Exclusion Criteria: - Patient with progressive cancer pain - severe psychiatric pathology (example: psychosis, deep melancholy) - Patient not compliant or refusing to participate in research - Person who does not understand French, or illiterate - Person physically unable to complete questionnaires (visually impaired or blind) - Person protected by sections L1121-5 to L1121-8.1 of the French Public Health Code

Study Design


Related Conditions & MeSH terms


Intervention

Other:
questionnary SF36
This is a validate questionnary: Ware et al,1992, McHorney et al, 1993, McHorney et al, 1994 French version : Author : Alain Leple`ge; et coll. En 2001
Hospital Anxiety and Depression Scale
this is a validate scale: author: Zigmond A.S., Snaith R.P. in 1983
Chronic Pain Acceptance Questionnaire
This is a validate questionnaire: Fish, R., McGuire, B.E., Hogan, M., Stewart, I. & Morrison, T. (2010).
digital pain scale
this is a validate scale A.N.A.E.S. February 1999

Locations

Country Name City State
France CH Metropole Savoie Chambéry

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Metropole Savoie

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary change of quality of life during the program SF36 score score at the end of the workshop compared to the score at the beginning
Secondary Change in quality of life assessed by sf36 score Comparison between the beginning of the program and twelve months after the end of the program.
Secondary Change in anxiety and depression assessed by HADS Comparison at different moments in time - beginning, end, 6 months after, 12 months after
Secondary Change in perceived pain assessed by numeric pain scale Assessment at the beginning of the program and 12 months after the end using a numerical pain scale
Secondary Evolution in patient's acceptance of chronic pain:after the end assessed by Chronic Pain Acceptance Questionnaire Comparison at different moments in time - beginning, end, 6 months after, 12 months after
Secondary Change in physical activity assessed by SF36 Physical Activity Sub-Scale Change in physical activity between the beginning of the program and 12 months after the end
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain